Patent ID: 11919957
Assignee: BRISTOL-MYERS SQUIBB COMPANY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. The method of claim 1, wherein the anti-PD-1 antibody is administered:
at a weight based dose of 3 mg/kg body weight once every 2 weeks;
(ii) at a weight based dose of 5 mg/kg body weight once every 3 weeks;
(iii) at a weight based dose of 10 mg/kg body weight once every 3 weeks;
(iv) at a flat dose of about 240 mg once every 2 weeks;
(v) at a flat dose of about 360 mg once every 3 weeks; or
(vi) at a flat dose of about 480 mg once every 4 weeks.